Inventor
ANDERSON MARK B
US27 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON MARK B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLYCOMED INC
5 patentsUS5519008AMay 21, 1996
Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (E-selectin) and LECAM-1 (L-selectin)
GLYCOMED INC65 citations96
US5789385AAug 4, 1998
Sialyl Lewisx mimetics containing phenyl backbones
GLYCOMED INC68 citations94
US5837689ANov 17, 1998
Sialyl lewis-x mimetics containing naphthyl backbones
GLYCOMED INC40 citations92
US5527890AJun 18, 1996
Derivatives of triterpenoid acids and uses thereof
GLYCOMED INC17 citations82
US5624909AApr 29, 1997
Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (e-selectin) and LECAM-1 (l-selectin)
GLYCOMED INC8 citations73
ROCKWELL AUTOMATION TECH INC
4 patentsUS7314169B1Jan 1, 2008
Device that issues authority for automation systems by issuing an encrypted time pass
ROCKWELL AUTOMATION TECH INC99 citations97
US7716489B1May 11, 2010
Access control method for disconnected automation systems
ROCKWELL AUTOMATION TECH INC106 citations96
US7950044B2May 24, 2011
Centrally managed proxy-based security for legacy automation systems
ROCKWELL AUTOMATION TECH INC13 citations84
US9467289B2Oct 11, 2016
Method for obscuring a control device's network presence by dynamically changing the device's network addresses using a cryptography-based pattern
ROCKWELL AUTOMATION TECH INC2 citations63
WANDEL & GOLTERMANN TECHN INC
2 patentsANDERSON MARK B
2 patentsMYRIAD PHARMACEUTICALS INC
2 patentsMYREXIS INC
2 patentsUS7989462B2Aug 2, 2011
4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
MYREXIS INC4 citations60
US7842805B2Nov 30, 2010
Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
MYREXIS INC2 citations47